Stay updated on IMMUTACE Clinical Trial
Sign up to get notified when there's something new on the IMMUTACE Clinical Trial page.

Latest updates to the IMMUTACE Clinical Trial page
- CheckyesterdayChange DetectedThe page footer revision number is updated from v3.5.2 to v3.5.3, reflecting a site/version metadata change rather than content changes to the study record.SummaryDifference0.1%

- Check8 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Hepatocellular carcinoma as a topic and a Genetic and Rare Diseases Information Center resource, and updated the site revision to v3.5.0 (removing v3.4.3).SummaryDifference0.2%

- Check44 days agoChange DetectedThe page's revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.4.2 has been added and the v3.4.1 notice removed; these are administrative updates that do not affect the study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedThe page now shows a site-wide funding-status notice, and the revision is updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

Stay in the know with updates to IMMUTACE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMMUTACE Clinical Trial page.